Human Lung Cancer Cell NCI-H1975 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-217730) | Inquiry | Add to cart | |
| 0.5 ml(Cat-685428) | Inquiry | Add to cart | |
| 1.5 ml(Cat-685529) | Inquiry | Add to cart | |
| 8.0 ml(Cat-706731) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 94% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
NCI-H1975 is a type of lung cancer cell obtained from a patient with a specific type of lung cancer (adenocarcinoma). Scientists routinely use this cell line to study the pathogenesis of lung cancer and find new treatments. The cells were characterized by the presence of two genetic mutations that are more common in lung cancer - the epidermal growth factor receptor (EGFR) mutation and the T790M mutation. Because of this, they are well suited for the study of drug resistance in lung cancer and for finding new treatments to address resistance. Researchers have used NCI-H1975 cells to do a lot of research on lung cancer, how drugs work and how different treatments can be combined to fight cancer. CD BioSciences has a kit to help scientists work with these cells more easily.
